NCT00095342View on ClinicalTrials.gov

Study Evaluating TMI-005 in Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

TMI-005

Trial Locations (8)

13210

Syracuse

16635

Duncansville

19611

West Reading

46250

Indianapolis

H2L 1S6

Montreal

G1W 4R4

Ste-Foy

G8Z 1Y2

Trois-Rivières

S7K 0H6

Saskatoon

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00095342 - Study Evaluating TMI-005 in Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter